A Superhero challenge

Full Article

The prevalence of diabetes in Florida has increased nearly 70 percent in the past ten years. To address this challenge, “we have established a ‘new-age’ Diabetes and Obesity Research Center here in Orlando,” said Dr. Daniel Kelly, scientific director of Sanford-Burnham’s Orlando campus, located in the emerging Medical City at Lake Nona, as he addressed an enthusiastic audience at Bring It! Orlando on November 3.

For the many corporate and individual supporters attending the fundraising event, the fight against diabetes had personal significance as diabetes now affects one in 10 Floridians, and most alarmingly, has spread to the pediatric population.

Obesity is not one condition: an interview with Dr. Steven Smith

Full Article

Dr. Steven Smith is the scientific director of the Translational Research Institute for Metabolism and Diabetes, a collaboration between Sanford-Burnham and Florida Hospital. In a special presentation at Obesity 2011: The Obesity Society 29th Annual Scientific Meeting, held October 1-5 in Orlando, Fla., Dr. Smith discussed some up-and-coming anti-obesity agents, how they work, and how physicians might be able to put them to use. In his talk, he emphasized the importance of better understanding the fundamental cellular mechanisms that fuel obesity. With a greater appreciation for human metabolism, Dr. Smith explained, scientists will be able to develop new medications that focus less on appetite suppression (the target of most current weight loss drugs) and more on peripheral targets such as muscle or fat.

Fighting fat with fat

Full Article

The fat we typically think of as body fat is called white fat. But there’s another type—known as brown fat—that does more than just store fat. It burns fat. Scientists used to think that brown fat disappeared after infancy, but recent advances in imaging technology led to its rediscovery in adult humans. Because brown fat is so full of blood vessels and mitochondria—that’s what makes it brown—it’s very good at converting calories into energy, a process that malfunctions in obesity.

In a study published October 5 in Cell Metabolism, Sanford-Burnham researchers discovered that orexin, a hormone produced in the brain, activates calorie-burning brown fat in mice. Orexin deficiency is associated with obesity, suggesting that orexin supplementation could provide a new therapeutic approach for the treatment of obesity and other metabolic disorders. Most current weight loss drugs are aimed at reducing a person’s appetite. An orexin-based therapy would represent a new class of fat-fighting drugs—one that focuses on peripheral fat-burning tissue rather than the brain’s appetite control center.

“Our study provides a possible reason why some people are overweight or obese despite the fact that they don’t overeat—they might lack the orexin necessary to activate brown fat and increase energy expenditure,” explains Dr. Devanjan Sikder, senior author of the study and assistant professor in Sanford-Burnham’s Diabetes and Obesity Research Center, located in Orlando’s Medical City at Lake Nona.

Why are we so fat?

Full Article
A new report released by the Trust for America’s Health and the Robert Wood Johnson Foundation held dire news about the state of America’s obesity epidemic. The report, aptly named “F as in Fat: How Obesity Threatens America’s Future 2011,” revealed several eye-opening statistics. Here are a few:

• Twenty years ago, no state had an obesity rate above 15 percent. Now every state does.
• Today, 12 states have obesity rates over 30 percent. Four years ago, only one did.
•  Since 1995, diabetes rates (long associated with obesity) have doubled in eight states. Then, only four states had diabetes rates above six percent.  Now, 43 states have diabetes rates over seven percent, and 32 have rates above eight percent.

To understand why the nation’s weight problem has ballooned over the past two decades, obesity researchers are increasingly looking to our environment. The Orlando Sentinel interviewed obesity expert Dr. Steven R. Smith, Sanford-Burnham professor and scientific director of the Translational Research Institute for Metabolism and Diabetes (TRI), a collaboration between Florida Hospital and Sanford-Burnham. He said:

“Our genes haven’t changed that much in thousands of years, but we have seen a rapid change in the environment, and that has interacted with our genetic propensity toward obesity.”

Read more in How fat is America? New report gives nation an F.

Building translational research

Full Article

The  Translational Research Institute for Metabolism and Diabetes (TRI), a collaboration between Sanford-Burnham and Florida Hospital, is one step closer to opening its research facility. The 54,000 square-foot building recently reached its final height, and a special ceremony was held during which researchers gathered to sign one of the interior columns. Construction to enclose the building will now begin.The TRI, which studies diabetes, obesity and the metabolic origins of cardiovascular disease, will  help bridge the gap between the scientist’s laboratory and the patient’s bedside. The TRI will unite scientists, clinicians and advanced technologies to spur translational research and rapidly create new, more effective treatments.

“We are witnessing an epidemic of obesity and diabetes in the United States,” said Dr. Steven R. Smith, scientific director of the TRI. “The main goal of the TRI is to generate new knowledge to improve lives through innovative research. By ‘topping out’ the TRI, we are one step closer towards developing Orlando as a medical destination.”

Running for research

Full Article

You can share the glory this weekend as members of Team Sanford-Burnham participate in the Walt Disney World MarathonWeekend by running or walking the half or full marathon. On January 8 and 9, five long months of early mornings and late evenings spent in rigorous training will pay off for 47 champions of medical research. The money raised by the team will support biomedical research at Sanford-Burnham.Team Sanford-Burnham members are not experienced athletes, just ordinary people willing to make an extraordinary commitment. They will run alongside the very people whose work they are supporting. Our own CEO, Dr. John Reed, will participate in the marathon, as he does each year. Joining Dr. Reed from Sanford-Burnham are Dr. Dan Kelly, Scientific Director at Sanford-Burnham at Lake Nona, Dr. Timothy Osborne, Dr. Philip A. Wood and Elizabeth Gianini. You can track individual runners with Disney’s spectator tool.

Collaboration with Takeda seeks to translate research into treatments

Full Article

Sanford-Burnham, Florida Hospital and Takeda Pharmaceutical have formed a collaboration to investigate new therapies for obesity, a growing worldwide health problem. The partnership leverages the three organizations’ strengths in basic biomedical research, clinical research and drug development to identify obesity-related biomarkers and other targets with therapeutic potential.“There is an epidemic of obesity in the U.S.; two-thirds of Americans are now overweight or obese. These staggering statistics serve as a call for decisive action, including innovative bench-to-bedside translational research,” says Dr. Steven R. Smith, scientific director of the Florida Hospital-Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI). “This partnership with Takeda, TRI and Sanford-Burnham represents a major milestone in the quest for a better understanding of obesity as a disease and a pathway forward for the development of safe and effective therapies.”

New home for translational research

Full Article

Dr. Steven Smith, executive director of the Florida Hospital-Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI), took control of a backhoe to help demolish an old facility on the site of  TRI’s  new research building. The three-story facility will unite Sanford-Burnham’s laboratory research with Florida Hospital’s patient-oriented studies to translate basic science discoveries into new treatments.

“We are witnessing an epidemic of obesity and diabetes in the United States,”  said Dr. Smith. “Current statistics show that two-thirds of all Americans are overweight and obese and one in 12 has some form of diabetes. These staggering statistics call for decisive action and that includes innovative research.”

The new TRI facility will contain clinic space, testing rooms, medical imaging, a biorepository and advanced technologies to develop personalized treatments. The new facility is expected to be completed by the end of 2011.

“The TRI provides a virtual bridge between Florida Hospital’s Orlando campus and Medical City at Lake Nona,” said Dr. Daniel Kelly, scientific director at Sanford-Burnham at Lake Nona.  “Instead of cars, information will speed back and forth on the bridge to accelerate discoveries leading to new treatments.”

Governor-elect Tours Sanford-Burnham to Highlight Job Creation

Full Article

Florida’s Governor-elect Rick Scott rolled into Orlando’s Medical City to visit Sanford-Burnham as the final stop on a five-day, statewide tour to discuss jobs and economic development.  Dr. Daniel Kelly, scientific director of Sanford-Burnham at Lake Nona, showed the governor-elect around Sanford-Burnham’s Florida campus, which researches diabetes, obesity and cardiovascular disease.  Dr. Kelly explained his research on energy metabolism in muscles, which was recently published in the journal Cell Metabolism, and then introduced Dr. Philip Wood, who surprised the governor-elect by presenting him with a five-pound model of fat as he explained the medical complications that arise from obesity.

More than 200 business and civic leaders listened to Governor-elect Scott’s comments on economic growth. “My first priority is to hear first-hand from Florida’s business and industry representatives their solutions for creating good paying jobs here in Florida,” he said.

TEDx3: three days, three cities, three experiences

Full Article

Can’t get enough TED? Neither can we. All three of Sanford-Burnham’s home cities have recently hosted TEDx conferences. In October, Dr. Jamey Marth wowed Santa Barbara with the future of nanomedicine at TEDxAmericanRiviera. Last month, Dr. Devanjan Sikder talked obesity at the inaugural TEDxOrlando and I recently had the chance to attend TEDxSanDiego.

Like most participants (we were considered participants, not just an audience), I have long admired TED talks and jumped at the chance to see one in person. TED (short for Technology, Entertainment, Design) has become so popular that local TEDx spin-offs (where x = independently organized) are springing up everywhere. The TED formula for community building brings together people who are passionate about ideas that matter and creates a forum where people with big ideas can connect.

Top 10 reasons to be thankful for science

Full Article

It’s that time of year when we pause to remember what we’re thankful for. We can think of many reasons to be thankful for science. Here are the top 10:

Beacause science…
10.  says fat can be good
9. uncovers new drug targets
8. is art
7. turns disease on its head
6. finds new uses for old drugs
5. inspires kids
4. is better than science fiction
3. explains how cancer works
2. provides a “do-over”

And the #1 reason we are thankful for science? Because it saves lives (and makes them better).

Why are you thankful for Science? Please leave a comment below…and have a Happy Thanksgiving!

Rocking Out for Research

Full Article

Last night at the Hard Rock Live in Orlando, Florida, scientists, business people and public servants  gathered to “Bring It!” for medical research. Bring It! was Sanford-Burnham at Lake Nona’s first major fundraising event and one that attendees will not soon forget.

Three hundred people beat drum sticks on their tables in enthusiasm as the event began. Celebrity impersonators, including ZZ Top, John Lennon and Yoko Ono and stilt-walking members of KISS, added to the fun. MC Marvelless Mark performed his own rendition of “We Will Rock You,” and reminded everyone why they were there—to raise funds that will help cure diseases like cancer and diabetes. The main event included game show-style challenges and trivia that encouraged all participants to unleash their inner rock stars. Whether they sang, decorated lab coats or just fell off their chairs laughing at the antics, everyone had a ball.

Running for Research

Full Article

Judy Wade is all smiles, arriving at Sanford-Burnham’s La Jolla campus sporting shorts and a T-shirt that reads, “Will Run for Coffee.” She really means it. Though she never ran before joining Team Sanford-Burnham, it now seems that running is part of Wade’s identity.The annual run with Team Sanford-Burnham allows participants to run side-by-side with the very scientists whose work they are supporting. “When they formed this team about five years ago, I thought it would be a good idea to do something new for a good cause,” Wade recalls. “I wasn’t a runner. I didn’t even like it, but now I love it.”

New York Times Highlights Sanford-Burnham’s Orlando Campus

Full Article

The real estate section of today’s New York Times featuresOrlando’s Medical City in Lake Nona, an emerging research hub that was founded in part with Sanford-Burnham’s  campus:

As soon as the [University of Central Florida] medical school was approved in 2006, the Burnham Institute (now called the Sanford-Burnham Medical Research Institute after a recent $50 million donation by the billionaire T. Denny Sanford) chose Lake Nona for its new home. The building, which opened last year, contains one of the country’s few robotic high-throughput screening centers — machines that can run a huge number of biological tests very quickly.

In addition to Sanford-Burnham and the University of Central Florida’s College of Medicine, Lake Nona’s Medical City currently includes MD Anderson Cancer Center Orlando. The hub will also soon welcome the University of Florida Academic and Research Center, a new Veteran’s Affairs Medical Center and Nemours Children’s Hospital.

While Medical City has been a boon for economic development, it’s also been great for scientific collaboration:

“A lot of Sanford-Burnham researchers have similar interests with ours,” said Roger Oxendale, the chief executive of Nemours. “A lot of the questions they’ll be asking about diabetes and obesity, they’ll be asking with respect to childhood diseases. I think we haven’t realized the potential of these partnerships.”

For a more complete history of Medical City at Lake Nona, read the entire New York Times article, “Orlando’s Newest Attraction is Medical”.

Welcome to “MeD Camp”

Full Article

Scientists at Sanford-Burnham’s Lake Nona campus recently hosted 26 high school students from surrounding Orlando schools during the second annual Medical Summer Camp (MeD Camp), a joint project with Florida Hospital that introduces students to life science careers.